SlideShare a Scribd company logo
University of Mosul
College of Medicine
Lecture: Neoplasia , lecture No. 5
Subject/year: Neoplasia / 2022
Lecturer: Prof. Dr. Wahda M.T. Al -Nuaimy
Department: Pathology.
Date: 22-11-2022
The AIM of this lecture is
• Molecular basis of cancer.
• The four classes of normal regulatory genes are
involved in carcinogenesis.
• Host defense against tumors.
• Mechanisms developed by tumor cells to
escape or evade immune system.
• Cellular and molecular hallmarks of cancer.
Intended learning outcomes:
• To explain the molecular basis of cancer.
• To discuss the four classes of normal regulatory
genes are involved in carcinogenesis.
• To define the host defense against tumors.
• To identify the mechanisms developed by tumor
cells to escape or evade immune system.
• To verify the cellular and molecular hallmarks of
cancer.
 Nonlethal genetic damage, the initial damage (or
mutation) may be :
A) Acquired by environmental factors such as:
- Radiation
- Chemical substances
- Viruses
B) Inherited in the germ line cells , e.g. Familial
adenomatous polyps (APC gene) autosomal dominant
disorder.
 A tumor is formed by the clonal expansion of a single
precursor (progenitor) cell that has incurred genetic
damage (i.e., tumors are clonal).
Molecular basis of cancer
 Involvement of normal regulatory genes.
 Four classes of normal regulatory genes are
involved in carcinogenesis.
1. Proto-oncogenes.
2. Tumor Suppressor Genes.
3. Programmed cell death genes.
4. DNA repair genes.
There are several possible ways of
proto-oncogene activation :
• 1-Point mutation :
e.g. RAS gene in esophageal, colonic and
pancreatic tumors.
• 2- Amplification:
e.g. HER 2 in breast cancer.
• 3-Translocation to a transcriptionally active site ;
e.g. Burkitt lymphoma due to translocation of MYS
oncogene into immunoglobulin locus.
• 4- Fusion gene creation due to chromosomal
rearrangement ;
Translocation between chromosome 9 and 22
(BCR_ABL fusion gene in CML) .
2- Tumor Suppressor Genes
These are genes whose products normally stop
a cell growing, or trigger checkpoints that cause
cell cycle arrest if DNA damage occurs.
tumor suppressor genes are cell cycle arrest genes or
DNA repair genes, e.g.:
• Mutant P53 gene (found in more than 50% of
cancers).
• Mutant APC gene →Familial adenomatous polyps
• Mutant Rb gene → Retinoblastoma.
P53
• A very important gene; it is the guardian of the genome
or the molecular policeman (P53 prevents replication
of damagedDNA)
• P53 prevents neoplastic transformation by three
interlocking mechanisms:
By activation of temporary cell cycle arrest (quiescence)
Or induction of permanent cell cycle arrest (senescence)
Or triggering of programmed cell death (apoptosis).
The role of P53 in maintaining the integrity of genome
3- programmed cell death genes:
(apoptosis)
• Tumor mass may result not only from activation
of growth-promoting oncogenes or
inactivation of growth-suppressing tumor
suppressor genes, but also from mutations in
the genes that regulate apoptosis.
• e.g. overexpression of BCL-2 ( anti-apoptotic gene)
in follicular B cell lymphomas.
4. DNA repair genes
• These genes are code for proteins whose
normal function is correct errors in DNA.
• DNA repair genes are active throughout the cell
cycle , particularly during G2 after DNA
replication and before chromosomal division.
• Mutations in DNA repair genes can lead to a
failure in repair, which in turn allow
subsequent mutations to accumulate.
• If the rate of DNA damage exceeds the capacity
of the cell to repair it, the accumulation of
errors can result in cancer.
Xeroderma pigmentosum
Changes of the skin include marked
freckly hyperpigmentation, atrophy, and
numerous warty & nodular growths.
Host Defense against tumors
(Antitumor Effector Mechanisms)
-Tumor cells can be recognized by the immune system as
non-self and destroyed.
-Cell-mediated immunity is the dominant antitumor
mechanism.
• Cytotoxic T-lymphocytes (CD8+ T-Cells) ,NK cells &
Macrophages.
-Although sera from cancer patients may contain antibodies
that recognize tumors, there is limited evidence that they play
a protective role under physiologic conditions.
-Tumor antigens are presented on the cell surface by
MHC class I molecules and are recognized by CD8+
cytotoxic T-lymphocytes.
Mechanisms
by which
tumors
evade the
immune
system.
Eight Cellular and Molecular Hallmarks of Cancer
1) Self-sufficiency in growth signals.
2) Insensitivity to growth-inhibitory signals.
3) Altered cellular metabolism.
4) Evasion of apoptosis: Tumors are resistant to
programmed cell death.
5) Limitless replicative potential: Tumors have
unrestricted proliferative capacity, a stem cell–like
property.
6) Sustained angiogenesis.
7) Ability to invade and metastasize.
8) Ability to evade the host immune response
AGE
• Cancer is most common in those over 55 years of age,
a fact pointing that cancer evolution requires multiple
independent events, apparently taking place over a
long periods of time.
• Certain tumors are particularly common in children
(under 15 years of age), these include
• Leukemias and lymphomas.
• neuroblastomas .
• Wilms’tumor ( nephroblastoma).
• Ewing’s sarcoma .
• Osteosarcoma.
• Rhabdomyosarcoma .
• Retinoblastoma.
HEREDITY
• Heredity plays a role in the development of cancer
even in the presence of clearly defined
environmental factors.
• Hereditary forms of cancer can be divided into
three categories.
1- Inherited cancer syndromes.
The predisposition to tumor is an autosomal
dominant trait, as exemplified by Familial
Retinoblastoma and Familial Adenomatous
Polyposis Coli (FAPC).
2- Familial cancers: These are characterized by
familial clustering of specific forms of cancer,
Familial forms of breast, colon, brain and
ovarian cancer are recorded.
Sometimes tumors are linked to certain genes
such as the linkage of BRCA-1 & BRCA-2 to
familial breast & ovarian cancers.
3- Autosomal recessive syndromes of defective
DNA repair e.g., Xeroderma pigmentosa.
To summarize :
Four classes of normal regulatory genes are involved in carcinogenesis.
1. Proto-oncogenes.
2. Tumor Suppressor Genes.
3. Programmed cell death genes.
4. DNA repair genes.
Eight Cellular and Molecular Hallmarks of Cancer
1) Self-sufficiency in growth signals.
2) Insensitivity to growth-inhibitory signals.
3) Altered cellular metabolism.
4) Evasion of apoptosis: Tumors are resistant to programmed cell death.
5) Limitless replicative potential: Tumors have unrestricted proliferative
capacity, a stem cell–like property.
6) Sustained angiogenesis.
7) Ability to invade and metastasize.
8) Ability to evade the host immune response.
MCQ:
One of the following is cancer suppressor gene
a. Her- 2
b. RAS gene.
c. BCL-2.
d. mutant Rb gene.
e. Bax gene.
All of the following malignant tumors are common in children
except
•
a. Neuroblastomas .
b. Wilms’tumor.
c. Ewing’s sarcoma.
d. Retinoblastoma.
e. lung cancer.
Home work??
Try to make MCQ questions about the information
get it’s from this lecture!!
Thank you

More Related Content

Similar to Neoplasia 5 new.ppt

Molecular biology of cancer
Molecular biology of cancerMolecular biology of cancer
Molecular biology of cancer
Nawfal Aldujaily
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
Mammootty Ik
 
Carcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfCarcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdf
MohitChauhan270470
 
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Rahul Kadam
 
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsTUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
Dr. Roopam Jain
 
Host tumor.pptx
Host tumor.pptxHost tumor.pptx
Host tumor.pptx
MohammadFaisal565026
 
Cancer by online teaching ot
Cancer by online teaching otCancer by online teaching ot
Cancer by online teaching ot
vidan biology
 
Cancer and tumor markers
Cancer and tumor markersCancer and tumor markers
Cancer and tumor markers
Kshema Thakur
 
CANCER (Overview).docx
CANCER (Overview).docxCANCER (Overview).docx
CANCER (Overview).docx
CnetteSLumbo
 
Cancer biology.pdf
Cancer biology.pdfCancer biology.pdf
Cancer biology.pdf
amanuelzeru
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
VandanaChandan1
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
Rahul Netragaonkar
 
Anticancer.ppt
Anticancer.pptAnticancer.ppt
Anticancer.ppt
Manish Gautam
 
Cancer
CancerCancer
Cancer
CancerCancer
بدر الشهاري.ppt
بدر الشهاري.pptبدر الشهاري.ppt
بدر الشهاري.ppt
osama727046
 
Advanced tumor immunology prof dr.ihsan edan alsaimary university of basrah...
Advanced tumor immunology prof dr.ihsan edan alsaimary   university of basrah...Advanced tumor immunology prof dr.ihsan edan alsaimary   university of basrah...
Advanced tumor immunology prof dr.ihsan edan alsaimary university of basrah...
dr.Ihsan alsaimary
 
1. introduction of chemotherapy of cancer
1. introduction of chemotherapy of cancer1. introduction of chemotherapy of cancer
1. introduction of chemotherapy of cancer
HarshikaPatel6
 

Similar to Neoplasia 5 new.ppt (20)

Molecular biology of cancer
Molecular biology of cancerMolecular biology of cancer
Molecular biology of cancer
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Carcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfCarcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdf
 
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...
 
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsTUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
 
Host tumor.pptx
Host tumor.pptxHost tumor.pptx
Host tumor.pptx
 
Cancer by online teaching ot
Cancer by online teaching otCancer by online teaching ot
Cancer by online teaching ot
 
Cancer and tumor markers
Cancer and tumor markersCancer and tumor markers
Cancer and tumor markers
 
CANCER (Overview).docx
CANCER (Overview).docxCANCER (Overview).docx
CANCER (Overview).docx
 
Cancer biology.pdf
Cancer biology.pdfCancer biology.pdf
Cancer biology.pdf
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
Anticancer.ppt
Anticancer.pptAnticancer.ppt
Anticancer.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
Cancer
CancerCancer
Cancer
 
Cancer
CancerCancer
Cancer
 
بدر الشهاري.ppt
بدر الشهاري.pptبدر الشهاري.ppt
بدر الشهاري.ppt
 
Advanced tumor immunology prof dr.ihsan edan alsaimary university of basrah...
Advanced tumor immunology prof dr.ihsan edan alsaimary   university of basrah...Advanced tumor immunology prof dr.ihsan edan alsaimary   university of basrah...
Advanced tumor immunology prof dr.ihsan edan alsaimary university of basrah...
 
1. introduction of chemotherapy of cancer
1. introduction of chemotherapy of cancer1. introduction of chemotherapy of cancer
1. introduction of chemotherapy of cancer
 

Recently uploaded

Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 

Neoplasia 5 new.ppt

  • 1. University of Mosul College of Medicine Lecture: Neoplasia , lecture No. 5 Subject/year: Neoplasia / 2022 Lecturer: Prof. Dr. Wahda M.T. Al -Nuaimy Department: Pathology. Date: 22-11-2022
  • 2. The AIM of this lecture is • Molecular basis of cancer. • The four classes of normal regulatory genes are involved in carcinogenesis. • Host defense against tumors. • Mechanisms developed by tumor cells to escape or evade immune system. • Cellular and molecular hallmarks of cancer.
  • 3. Intended learning outcomes: • To explain the molecular basis of cancer. • To discuss the four classes of normal regulatory genes are involved in carcinogenesis. • To define the host defense against tumors. • To identify the mechanisms developed by tumor cells to escape or evade immune system. • To verify the cellular and molecular hallmarks of cancer.
  • 4.  Nonlethal genetic damage, the initial damage (or mutation) may be : A) Acquired by environmental factors such as: - Radiation - Chemical substances - Viruses B) Inherited in the germ line cells , e.g. Familial adenomatous polyps (APC gene) autosomal dominant disorder.  A tumor is formed by the clonal expansion of a single precursor (progenitor) cell that has incurred genetic damage (i.e., tumors are clonal). Molecular basis of cancer
  • 5.  Involvement of normal regulatory genes.  Four classes of normal regulatory genes are involved in carcinogenesis. 1. Proto-oncogenes. 2. Tumor Suppressor Genes. 3. Programmed cell death genes. 4. DNA repair genes.
  • 6.
  • 7. There are several possible ways of proto-oncogene activation : • 1-Point mutation : e.g. RAS gene in esophageal, colonic and pancreatic tumors. • 2- Amplification: e.g. HER 2 in breast cancer.
  • 8.
  • 9. • 3-Translocation to a transcriptionally active site ; e.g. Burkitt lymphoma due to translocation of MYS oncogene into immunoglobulin locus. • 4- Fusion gene creation due to chromosomal rearrangement ; Translocation between chromosome 9 and 22 (BCR_ABL fusion gene in CML) .
  • 10. 2- Tumor Suppressor Genes These are genes whose products normally stop a cell growing, or trigger checkpoints that cause cell cycle arrest if DNA damage occurs. tumor suppressor genes are cell cycle arrest genes or DNA repair genes, e.g.: • Mutant P53 gene (found in more than 50% of cancers). • Mutant APC gene →Familial adenomatous polyps • Mutant Rb gene → Retinoblastoma.
  • 11. P53 • A very important gene; it is the guardian of the genome or the molecular policeman (P53 prevents replication of damagedDNA) • P53 prevents neoplastic transformation by three interlocking mechanisms: By activation of temporary cell cycle arrest (quiescence) Or induction of permanent cell cycle arrest (senescence) Or triggering of programmed cell death (apoptosis).
  • 12.
  • 13.
  • 14.
  • 15. The role of P53 in maintaining the integrity of genome
  • 16. 3- programmed cell death genes: (apoptosis) • Tumor mass may result not only from activation of growth-promoting oncogenes or inactivation of growth-suppressing tumor suppressor genes, but also from mutations in the genes that regulate apoptosis. • e.g. overexpression of BCL-2 ( anti-apoptotic gene) in follicular B cell lymphomas.
  • 17. 4. DNA repair genes • These genes are code for proteins whose normal function is correct errors in DNA. • DNA repair genes are active throughout the cell cycle , particularly during G2 after DNA replication and before chromosomal division.
  • 18. • Mutations in DNA repair genes can lead to a failure in repair, which in turn allow subsequent mutations to accumulate. • If the rate of DNA damage exceeds the capacity of the cell to repair it, the accumulation of errors can result in cancer.
  • 19. Xeroderma pigmentosum Changes of the skin include marked freckly hyperpigmentation, atrophy, and numerous warty & nodular growths.
  • 20.
  • 21. Host Defense against tumors (Antitumor Effector Mechanisms) -Tumor cells can be recognized by the immune system as non-self and destroyed. -Cell-mediated immunity is the dominant antitumor mechanism. • Cytotoxic T-lymphocytes (CD8+ T-Cells) ,NK cells & Macrophages. -Although sera from cancer patients may contain antibodies that recognize tumors, there is limited evidence that they play a protective role under physiologic conditions. -Tumor antigens are presented on the cell surface by MHC class I molecules and are recognized by CD8+ cytotoxic T-lymphocytes.
  • 23. Eight Cellular and Molecular Hallmarks of Cancer 1) Self-sufficiency in growth signals. 2) Insensitivity to growth-inhibitory signals. 3) Altered cellular metabolism. 4) Evasion of apoptosis: Tumors are resistant to programmed cell death. 5) Limitless replicative potential: Tumors have unrestricted proliferative capacity, a stem cell–like property. 6) Sustained angiogenesis. 7) Ability to invade and metastasize. 8) Ability to evade the host immune response
  • 24. AGE • Cancer is most common in those over 55 years of age, a fact pointing that cancer evolution requires multiple independent events, apparently taking place over a long periods of time. • Certain tumors are particularly common in children (under 15 years of age), these include • Leukemias and lymphomas. • neuroblastomas . • Wilms’tumor ( nephroblastoma). • Ewing’s sarcoma . • Osteosarcoma. • Rhabdomyosarcoma . • Retinoblastoma.
  • 25. HEREDITY • Heredity plays a role in the development of cancer even in the presence of clearly defined environmental factors. • Hereditary forms of cancer can be divided into three categories. 1- Inherited cancer syndromes. The predisposition to tumor is an autosomal dominant trait, as exemplified by Familial Retinoblastoma and Familial Adenomatous Polyposis Coli (FAPC).
  • 26. 2- Familial cancers: These are characterized by familial clustering of specific forms of cancer, Familial forms of breast, colon, brain and ovarian cancer are recorded. Sometimes tumors are linked to certain genes such as the linkage of BRCA-1 & BRCA-2 to familial breast & ovarian cancers. 3- Autosomal recessive syndromes of defective DNA repair e.g., Xeroderma pigmentosa.
  • 27.
  • 28. To summarize : Four classes of normal regulatory genes are involved in carcinogenesis. 1. Proto-oncogenes. 2. Tumor Suppressor Genes. 3. Programmed cell death genes. 4. DNA repair genes. Eight Cellular and Molecular Hallmarks of Cancer 1) Self-sufficiency in growth signals. 2) Insensitivity to growth-inhibitory signals. 3) Altered cellular metabolism. 4) Evasion of apoptosis: Tumors are resistant to programmed cell death. 5) Limitless replicative potential: Tumors have unrestricted proliferative capacity, a stem cell–like property. 6) Sustained angiogenesis. 7) Ability to invade and metastasize. 8) Ability to evade the host immune response.
  • 29. MCQ: One of the following is cancer suppressor gene a. Her- 2 b. RAS gene. c. BCL-2. d. mutant Rb gene. e. Bax gene. All of the following malignant tumors are common in children except • a. Neuroblastomas . b. Wilms’tumor. c. Ewing’s sarcoma. d. Retinoblastoma. e. lung cancer.
  • 30. Home work?? Try to make MCQ questions about the information get it’s from this lecture!!
  • 31.